title: T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma.
authors.affiliation: Department of Tumor Biology, Institut Curie, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Vincent-Salomon
authors.forename: C
authors.initials: C
authors.lastname: Mathiot
authors.forename: E
authors.initials: E
authors.lastname: Macintyre
authors.forename: V
authors.initials: V
authors.lastname: Girre
authors.forename: A
authors.initials: A
authors.lastname: Fourquet
authors.forename: C
authors.initials: C
authors.lastname: Mercier
authors.forename: P
authors.initials: P
authors.lastname: Fréneaux
authors.forename: J
authors.initials: J
authors.lastname: Dumont
authors.forename: D
authors.initials: D
authors.lastname: Decaudin
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000473:pathology*; D016393:Lymphoma, B-Cell / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D000069283:Rituximab; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab